Effect of Self-administered Auricular Acupressure on Smoking Cessation—a Pilot Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01389622 |
Recruitment Status
: Unknown
Verified March 2014 by Queen's University.
Recruitment status was: Recruiting
First Posted
: July 8, 2011
Last Update Posted
: November 18, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Smoking Cessation | Other: acupuncture | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Effect of Self-administered Auricular Acupressure on Smoking Cessation—a Pilot Study |
Study Start Date : | July 2011 |
Estimated Primary Completion Date : | December 2015 |
Estimated Study Completion Date : | January 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Arm 1: NADA points and digital pressure
Arm 1: NADA points and digital pressure with urge.
|
Other: acupuncture
National Acupuncture Detoxification Association (NADA) points + digital pressure
|
Experimental: Arm 2: random points + digital pressure with urge
Arm 2 (20 participants): random points + digital pressure with urge
|
Other: acupuncture
random points + digital pressure
|
No Intervention: Arm 3 (20 participants): NO acupressure, only advice + support |
- Spot 7-day cessation rate [ Time Frame: Weekly during the intervention period (weeks 1-6) ]Efficacy of intervention for smoking cessation
- Continuous Cessation Rate (CAR) [ Time Frame: Weekly during the intervention period (weeks 1-6) and week 13 and week 26 ]Efficacy of intervention for smoking cessation
- End-expiratory carbon monoxide levels (CO) [ Time Frame: Weekly during the intervention period (weeks 1-6) and week 13 and week 26 ]Efficacy of intervention for smoking cessation
- Adverse effects in terms of self-reported discomfort levels from auricular acupressure [ Time Frame: Weekly during the intervention period (weeks 1-6) ]Nature and incidence of adverse events due to intervention
- Stress level according to the Stress Check List (SCL) [ Time Frame: Weekly during the intervention period (weeks 1-6) and week 13 and week 26 ]Nature and incidence of adverse events due to intervention
- Nicotine withdrawal symptoms according to Minnesota Nicotine Withdrawal Scale (MNWS) [ Time Frame: Weekly during the intervention period (weeks 1-6) and week 13 and week 26 ]Nature and incidence of adverse events due to intervention

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
-
Participants are included in the study if they satisfy the following criteria:
- Male or female.
- Between 18 and 75 years of age inclusive.
- Able to provide informed consent to study.
- History of tobacco cigarette smoking for at least 6 months.
- Confirmed intention of smoking cessation with no more than 2 previous failed attempts in the last 3 year.
Exclusion Criteria:
- Existing pharmacotherapy for smoking cessation.
- History of major psychiatric disorder or chronic pain syndromes.
- More than 2 failed attempts of smoking cessation in the previous 3 years.
- History of other substance abuse.
- History of atopy, or suspected/known allergy to plaster.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01389622
Contact: Lawrence Leung, MD | 613-533-9303 | lawrence.leung@dfm.queensu.ca | |
Contact: Jyoti Kotecha, MPA | 613-533-6000 ext 73970 | jyoti.kotecha@cspc.queensu.ca |
Canada, Ontario | |
Queen's Family Health Team | Recruiting |
Kingston, Ontario, Canada, K7L 5E9 | |
Contact: Lawrence Leung, MD 613-533-9300 | |
Contact: Jyoti Kotecha, MPA 613-533-6000 ext 73970 jyoti.kotecha@dfm.queensu.ca |
Principal Investigator: | Lawrence Leung, MD | Queen's University |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Queen's University |
ClinicalTrials.gov Identifier: | NCT01389622 History of Changes |
Other Study ID Numbers: |
SMC01 |
First Posted: | July 8, 2011 Key Record Dates |
Last Update Posted: | November 18, 2014 |
Last Verified: | March 2014 |
Keywords provided by Queen's University:
Acupuncture smoking cessation |